These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2051730)

  • 1. Polyamines in the anemia of end-stage renal disease.
    Kushner D; Beckman B; Nguyen L; Chen S; Della Santina C; Husserl F; Rice J; Fisher JW
    Kidney Int; 1991 Apr; 39(4):725-32. PubMed ID: 2051730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease.
    McGonigle RJ; Boineau FG; Beckman B; Ohene-Frempong K; Lewy JE; Shadduck RK; Fisher JW
    J Lab Clin Med; 1985 Apr; 105(4):449-58. PubMed ID: 3981057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anemia of end-stage renal disease: hematopoietic progenitor cell response.
    Segal GM; Eschbach JW; Egrie JC; Stueve T; Adamson JW
    Kidney Int; 1988 May; 33(5):983-8. PubMed ID: 3392887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of spermine as an inhibitor of erythropoiesis in patients with chronic renal failure.
    Radtke HW; Rege AB; LaMarche MB; Bartos D; Bartos F; Campbell RA; Fisher JW
    J Clin Invest; 1981 Jun; 67(6):1623-9. PubMed ID: 7240411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyamines as an inhibitor on erythropoiesis of hemodialysis patients by in vitro bioassay using the fetal mouse liver assay.
    Yoshida K; Yoneda T; Kimura S; Fujimoto K; Okajima E; Hirao Y
    Ther Apher Dial; 2006 Jun; 10(3):267-72. PubMed ID: 16817792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of high molecular weight substances from CAPD dialysate on mouse bone marrow progenitor cells and lymphocyte transformation.
    Yang CL; Du XH; Wu H
    Chin Med J (Engl); 1994 Apr; 107(4):248-53. PubMed ID: 8088189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-stage renal disease following polycythemia vera: in vitro and in vivo response of erythroid progenitors to erythropoietin and effects of sera on normal erythropoiesis.
    Shih LY; Huang JY
    Nephron; 1998; 79(2):142-7. PubMed ID: 9647492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of uremic toxins in exacerbating anemia in renal failure.
    Macdougall IC
    Kidney Int Suppl; 2001 Feb; 78():S67-72. PubMed ID: 11168986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Erythropoietin levels and inhibitors of erythropoiesis in patients with chronic renal failure.
    Fukushima Y; Fukuda M; Yoshida K; Yamaguchi A; Nakamoto Y; Miura AB; Harada T; Tsuchida S
    Tohoku J Exp Med; 1986 Sep; 150(1):1-15. PubMed ID: 3775768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spermine and spermidine are non-specific inhibitors of in vitro hematopoiesis.
    Segal GM; Stueve T; Adamson JW
    Kidney Int; 1987 Jan; 31(1):72-6. PubMed ID: 3560647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
    Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
    Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of CFU-E colony formation in uremic patients with inflammatory disease: role of IFN-gamma and TNF-alpha.
    Allen DA; Breen C; Yaqoob MM; Macdougall IC
    J Investig Med; 1999 May; 47(5):204-11. PubMed ID: 10361379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic inhibitors in chronic renal failure: lack of in vitro specificity.
    Delwiche F; Segal GM; Eschbach JW; Adamson JW
    Kidney Int; 1986 Mar; 29(3):641-8. PubMed ID: 3702219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of erythropoiesis by sera from patients with chronic renal failure.
    Hotta T; Maeda H; Suzuki I; Chung TG; Saito A
    Proc Soc Exp Biol Med; 1987 Oct; 186(1):47-51. PubMed ID: 3628251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric protein-polyamine conjugates: a new class of uremic toxins affecting erythropoiesis.
    Galli F; Beninati S; Benedetti S; Lentini A; Canestrari F; Tabilio A; Buoncristiani U
    Kidney Int Suppl; 2001 Feb; 78():S73-6. PubMed ID: 11168987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency.
    McGonigle RJ; Wallin JD; Shadduck RK; Fisher JW
    Kidney Int; 1984 Feb; 25(2):437-44. PubMed ID: 6727139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I plays a role in regulating erythropoiesis in patients with end-stage renal disease and erythrocytosis.
    Shih LY; Huang JY; Lee CT
    J Am Soc Nephrol; 1999 Feb; 10(2):315-22. PubMed ID: 10215331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of different modes of dialysis on serum erythropoietin levels in pediatric patients. A report of the Southwest Pediatric Nephrology Study Group.
    Beckman BS; Brookins JW; Shadduck RK; Mangan KF; Deftos LJ; Fisher JW
    Pediatr Nephrol; 1988 Oct; 2(4):436-41. PubMed ID: 3153056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of erythroid colony-forming cells (CFU-E and BFU-E) in sera of azotemic patients with anemia of renal disease.
    Ohno Y; Rege AB; Fisher JW; Barona J
    J Lab Clin Med; 1978 Dec; 92(6):916-23. PubMed ID: 739170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anemia of chronic renal failure: inhibition of erythropoiesis by uremic serum.
    Freedman MH; Cattran DC; Saunders EF
    Nephron; 1983; 35(1):15-9. PubMed ID: 6888621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.